These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19819485)

  • 1. [Oxidative stress and inflammatory markers in cocaine users with acute coronary syndrome].
    Domínguez-Rodríguez A; Abreu-González P; Enjuanes-Grau C; Blanco-Palacios G; Angeles Pérez-Carrillo Mde L; Burillo-Putze G
    Med Clin (Barc); 2010 Feb; 134(4):152-5. PubMed ID: 19819485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
    O'Conor K; Chang AM; Wu AH; Hollander JE
    Am J Emerg Med; 2013 Apr; 31(4):664-9. PubMed ID: 23380098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use.
    Hoskins MH; Leleiko RM; Ramos JJ; Sola S; Caneer PM; Khan BV
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):47-52. PubMed ID: 20133495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes.
    Spahić E; Hasić S; Kiseljaković E; Resić H; Kulić M
    Med Glas (Zenica); 2015 Aug; 12(2):128-32. PubMed ID: 26276649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
    Granér M; Tikkanen E; Rimpilä O; Tikkanen H; Ripatti S; Lokki ML; Nieminen MS; Taskinen MR; Sinisalo J
    Ann Med; 2013 Jun; 45(4):322-7. PubMed ID: 23651064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes.
    Carrillo X; Curós A; Muga R; Serra J; Sanvisens A; Bayes-Genis A
    Eur Heart J; 2011 May; 32(10):1244-50. PubMed ID: 21266375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome.
    Eren E; Ellidag HY; Yılmaz A; Aydın Ö; Yılmaz N
    Adv Med Sci; 2015 Mar; 60(1):89-93. PubMed ID: 25615956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
    De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome.
    Roy D; Quiles J; Avanzas P; Arroyo-Espliguero R; Sinha M; Kaski JC
    Int J Cardiol; 2006 May; 109(3):317-21. PubMed ID: 16046018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute Coronary Syndrome.
    González-Pacheco H; Amezcua-Guerra LM; Vazquez-Rangel A; Martínez-Sánchez C; Pérez-Méndez O; Verdejo J; Bojalil R
    Am J Cardiol; 2015 Dec; 116(11):1651-7. PubMed ID: 26456205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Zinc Measurement, Total Antioxidant Capacity, and Lipid Peroxide Among Acute Coronary Syndrome Patients With and Without ST Elevation.
    El-Mahdy RI; Mostafa MM; El-Deen HS
    Appl Biochem Biotechnol; 2019 May; 188(1):208-224. PubMed ID: 30417318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress.
    Undas A; Szułdrzynski K; Stepien E; Zalewski J; Godlewski J; Tracz W; Pasowicz M; Zmudka K
    Atherosclerosis; 2008 Feb; 196(2):551-7. PubMed ID: 17640649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute coronary syndrome and cocaine].
    Rodríguez-Esteban M; Mesa-Fumero J; Facenda-Lorenzo M; Dorta-Macías C; Ramos-López M; Soriano-Vela E
    Med Clin (Barc); 2009 Jun; 133(4):132-4. PubMed ID: 19371914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome.
    Lafitte M; Tastet S; Perez P; Serisé MA; Grandoulier AS; Aouizerate B; Sibon I; Capuron L; Couffinhal T
    BMC Cardiovasc Disord; 2015 Mar; 15():23. PubMed ID: 25888123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterising acute coronary syndrome-associated depression: Let the data speak.
    Vollmer-Conna U; Cvejic E; Granville Smith I; Hadzi-Pavlovic D; Parker G
    Brain Behav Immun; 2015 Aug; 48():19-28. PubMed ID: 25770081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.